DexCom
DXCM
#877
Rank
ยฃ21.11 B
Marketcap
ยฃ54.13
Share price
1.12%
Change (1 day)
-22.87%
Change (1 year)

Revenue for DexCom (DXCM)

Revenue in 2024: ยฃ3.21 Billion

According to DexCom's latest financial reports the company's current revenue (TTM ) is ยฃ3.34 Billion. In 2024 the company made a revenue of ยฃ3.21 Billion an increase over the revenue in the year 2023 that were of ยฃ2.84 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for DexCom from 2006 to 2024

Annual revenue

Year Revenue Change
2024ยฃ3.21 B13.03%
2023ยฃ2.84 B18.21%
2022ยฃ2.40 B32.6%
2021ยฃ1.81 B28.33%
2020ยฃ1.41 B25.58%
2019ยฃ1.12 B38.5%
2018ยฃ0.81 B52.87%
2017ยฃ0.53 B14.42%
2016ยฃ0.46 B71.28%
2015ยฃ0.27 B62.94%
2014ยฃ0.16 B71.64%
2013ยฃ96.99 M56.99%
2012ยฃ61.78 M25.92%
2011ยฃ49.06 M55.76%
2010ยฃ31.5 M71.68%
2009ยฃ18.34 M173.39%
2008ยฃ6.71 M188.18%
2007ยฃ2.32 M110.27%
2006ยฃ1.1 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
ยฃ68.26 B 1,940.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ32.47 B 870.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
ยฃ25.74 B 669.68%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
ยฃ16.17 B 383.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
ยฃ4.35 B 30.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
ยฃ0.74 B-77.70%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
ยฃ2.01 B-39.89%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
ยฃ2.23 B-33.17%๐Ÿ‡บ๐Ÿ‡ธ USA